• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Molli Surgical launches OncoPen 3D image guidance wand for breast cancer

Molli Surgical launches OncoPen 3D image guidance wand for breast cancer

April 10, 2024 By Danielle Kirsh

Molli Surgical's OncoPen on a white background.
OncoPen [Image courtesy of Molli Surgical]
Molli Surgical this week launched its OncoPen surgical tool for breast cancer imaging.

The sleek, pen-like wand integrates with the Deerfield, Illinois-based company’s Molli 2 system to precisely target and remove cancerous lesions, according to Molli Surgical. It’s a minimally invasive tool with directional 3D guidance.

OncoPen does not require wires and provides increased scheduling flexibility for surgeons while providing a better patient experience, according to Molli Surgical. The procedure involves the pre-surgical placement of a tiny Molli Marker near a breast cancer tumor. The surgeon is directed using real-time 3D guidance on the Molli Tablet to the precise location of the lesion.

The company said the precision of the OncoPen and Molli system allows for more targeted lesion removal, smaller surgical incisions, conservation of healthy tissues, and potentially improved cosmesis.

“The OncoPen is truly exciting. The pen-like design complements our workflow seamlessly, further enhancing the capabilities of the Molli 2 System. This combination boosts my confidence in our ability to tackle cancer with unmatched precision. It’s not just about technology; these tools empower us to deliver effective and compassionate care,” Dr. Jaime Alberty, Director of The Comprehensive Breast Center at NYC Health + Hospitals/Kings County, said in a news release.

Breast cancer prevalence is increasing globally, so advancements in minimally invasive and patient-centric surgical techniques is crucial, Molli Surgical said.

“At Molli Surgical, our relentless focus is on the patient, placing their well-being at the core of all our efforts,” President and CEO Ananth Ravi said. “We’ve dedicated ourselves to solving real clinical challenges, driven by a commitment to making a tangible difference in patient care. We’re profoundly grateful for the opportunity to improve the patient experience and continue to advance the field of surgical oncology with our innovations.”

The OncoPen is now available in conjunction with Molli Surgical’s Molli 2 system.

Medical Design & Outsourcing: Simplicity and studies were key for Molli’s magnetic surgical marker

Filed Under: Featured, Imaging, Mammography, Surgical, Women's Health Tagged With: Molli Surgical

More recent news

  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform
  • MiniMed completes split from Medtronic
  • GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy